Loading...
540025 logo

Advanced Enzyme Technologies LimitedBSE:540025 Stock Report

Market Cap ₹38.3b
Share Price
₹338.95
My Fair Value
₹436
22.3% undervalued intrinsic discount
1Y-26.8%
7D4.5%
Portfolio Value
View

Advanced Enzyme Technologies Limited

BSE:540025 Stock Report

Market Cap: ₹38.3b

Advanced Enzyme Technologies (540025) Stock Overview

Engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. More details

540025 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance1/6
Financial Health6/6
Dividends4/6

Rewards

Risk Analysis

No risks detected for 540025 from our risk checks.

540025 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Advanced Enzyme Technologies Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Advanced Enzyme Technologies
Historical stock prices
Current Share Price₹338.95
52 Week High₹571.15
52 Week Low₹257.85
Beta0.37
1 Month Change5.53%
3 Month Change11.61%
1 Year Change-26.80%
3 Year Change23.21%
5 Year Change47.40%
Change since IPO43.83%

Recent News & Updates

Recent updates

Shareholder Returns

540025IN ChemicalsIN Market
7D4.5%1.4%0.7%
1Y-26.8%-5.5%-6.8%

Return vs Industry: 540025 underperformed the Indian Chemicals industry which returned -5.5% over the past year.

Return vs Market: 540025 underperformed the Indian Market which returned -6.8% over the past year.

Price Volatility

Is 540025's price volatile compared to industry and market?
540025 volatility
540025 Average Weekly Movement5.9%
Chemicals Industry Average Movement5.1%
Market Average Movement5.2%
10% most volatile stocks in IN Market7.9%
10% least volatile stocks in IN Market3.3%

Stable Share Price: 540025 has not had significant price volatility in the past 3 months compared to the Indian market.

Volatility Over Time: 540025's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1957338n/awww.advancedenzymes.com

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It also provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids.

Advanced Enzyme Technologies Limited Fundamentals Summary

How do Advanced Enzyme Technologies's earnings and revenue compare to its market cap?
540025 fundamental statistics
Market cap₹38.27b
Earnings (TTM)₹1.37b
Revenue (TTM)₹6.68b
28.0x
P/E Ratio
5.7x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
540025 income statement (TTM)
Revenue₹6.68b
Cost of Revenue₹1.81b
Gross Profit₹4.87b
Other Expenses₹3.50b
Earnings₹1.37b

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)12.24
Gross Margin72.90%
Net Profit Margin20.48%
Debt/Equity Ratio2.7%

How did 540025 perform over the long term?

See historical performance and comparison

Dividends

1.5%
Current Dividend Yield
10%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/04 16:38
End of Day Share Price 2025/09/04 00:00
Earnings2025/06/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Advanced Enzyme Technologies Limited is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Nandan ChakrabortyAxis Capital Limited
Abhishek NavalgundCentrum Broking Limited
null nullDBS Bank Ltd